BE796276A - Nouveaux heterocycles a tete de pont leur procede de preparation et medicament les contenant - Google Patents

Nouveaux heterocycles a tete de pont leur procede de preparation et medicament les contenant

Info

Publication number
BE796276A
BE796276A BE128371A BE128371A BE796276A BE 796276 A BE796276 A BE 796276A BE 128371 A BE128371 A BE 128371A BE 128371 A BE128371 A BE 128371A BE 796276 A BE796276 A BE 796276A
Authority
BE
Belgium
Prior art keywords
heterocycles
preparation
product containing
medicinal product
new bridge
Prior art date
Application number
BE128371A
Other languages
English (en)
French (fr)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE796276A publication Critical patent/BE796276A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
BE128371A 1972-03-06 1973-03-05 Nouveaux heterocycles a tete de pont leur procede de preparation et medicament les contenant BE796276A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210633A DE2210633C2 (de) 1972-03-06 1972-03-06 Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BE796276A true BE796276A (fr) 1973-09-05

Family

ID=5838002

Family Applications (1)

Application Number Title Priority Date Filing Date
BE128371A BE796276A (fr) 1972-03-06 1973-03-05 Nouveaux heterocycles a tete de pont leur procede de preparation et medicament les contenant

Country Status (18)

Country Link
US (1) US3856798A (de)
JP (1) JPS5623993B2 (de)
AT (1) AT324336B (de)
BE (1) BE796276A (de)
CA (1) CA1016544A (de)
CH (1) CH593278A5 (de)
DD (1) DD106386A5 (de)
DE (1) DE2210633C2 (de)
ES (1) ES412321A1 (de)
FR (1) FR2181794B1 (de)
GB (1) GB1384504A (de)
HU (1) HU164568B (de)
IE (1) IE37368B1 (de)
IL (1) IL41669A (de)
NL (1) NL7303133A (de)
SE (1) SE414030B (de)
SU (1) SU525424A3 (de)
ZA (1) ZA731504B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971790A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US4093616A (en) * 1976-08-06 1978-06-06 Pfizer Inc. Quaternary salts as hypoglycemic agents
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
US5237089A (en) * 1986-02-07 1993-08-17 Basf Aktiengesellschaft Nitro or amino substituted phenylalkyl or phenylalkenyl carboxylic acid derivatives
DE3606168A1 (de) * 1986-02-26 1987-08-27 Basf Ag Zimtsaeurepropargylester, verfahren zu ihrer herstellung und ihre verwendung zur schaedlingsbekaempfung
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
IT1249210B (it) * 1990-06-08 1995-02-20 Boehringer Mannheim Italia ¬3h,7h| tiazolo-¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
IT1252626B (it) * 1991-12-06 1995-06-19 Boehringer Mannheim Italia ¬3h, 7h| tiazolo ¬3,4a| piridine ad attivita' antiasmatica ed antiinfiammatoria delle vie aeree
IT1252627B (it) * 1991-12-06 1995-06-19 Boehringer Mannehim Italia S P ¬3h,7h| tiazolo ¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
US5616775A (en) * 1994-05-05 1997-04-01 Bristol-Myers Squibb Co. Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
DE4444860A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784600A (en) * 1971-10-22 1974-01-08 Warner Lambert Co 4-substituted coumarins

Also Published As

Publication number Publication date
DD106386A5 (de) 1974-06-12
GB1384504A (en) 1975-02-19
SU525424A3 (ru) 1976-08-15
IE37368L (en) 1973-09-06
IE37368B1 (en) 1977-07-06
CH593278A5 (de) 1977-11-30
IL41669A (en) 1976-10-31
DE2210633C2 (de) 1983-09-22
US3856798A (en) 1974-12-24
ES412321A1 (es) 1976-01-01
HU164568B (de) 1974-03-28
SE414030B (sv) 1980-07-07
FR2181794A1 (de) 1973-12-07
IL41669A0 (en) 1973-08-29
CA1016544A (en) 1977-08-30
NL7303133A (de) 1973-09-10
DE2210633A1 (de) 1973-09-20
FR2181794B1 (de) 1976-10-22
ZA731504B (en) 1973-11-28
JPS4899193A (de) 1973-12-15
AT324336B (de) 1975-08-25
JPS5623993B2 (de) 1981-06-03

Similar Documents

Publication Publication Date Title
BE796276A (fr) Nouveaux heterocycles a tete de pont leur procede de preparation et medicament les contenant
BE827354A (fr) Nouveaux derives benzamidiques de pyrrolidine et piperidine, leur procede de preparation et medicament les contenant
BE800679A (fr) Nouvelle 1,4-dihydropyridines leur procede de preparation et medicament les contenant
BE804558A (fr) Nouveaux derives de 2-amino- ou 4-amino-quinazoline et medicaments les contenant
BE826900A (fr) Nouveaux derives 1-(4-phenoxy-phenyl)-1,3,5 triaziniques, leur triaziniques procede de preparation et medicament les contenant
FR2273546A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et medicament les contenant
BE855713Q (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant
BE795997A (fr) Nouveaux derives de l'insuline, leur procede de preparation et medicaments les contenant
FR2307543A1 (fr) Nouveaux amides peptidiques, leur procede de preparation et medicament les contenant
BE790441A (fr) Nouvelles penicillines, leur procede de preparation et medicament les contenant
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
FR2292471A1 (fr) Nouveaux antibiotiques du type b-lactame, leur procede de preparation et medicament les contenant
BE804092A (fr) Nouveaux 1-ethyl-imidazoles, leur procede de preparation et medicaments les contenant
BE831421A (fr) Nouvelles phenylisothiourees substituees, leur procede de preparation et medicament les contenant
BE789138A (fr) Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
FR2290211A1 (fr) Nouveaux 1,1-bioxydes de 4-hydroxy-2h-naphto (2,1-e)-1,2-thiazine-3-carboxamides, leur procede de preparation et medicaments les renfermant
BE805210A (fr) Nouveaux amides d'acides imidazoiylacetiques, leur procede de preparation et medicaments les contenant
BE835953A (fr) Nouveaux diaryloxy - imidazolyl - o,n - acetals, leur procede de preparation et medicament les contenant
FR2273530A2 (fr) Nouveaux acides et sels cyanophenylene-dioxamiques, leur procede de preparation et medicament les contenant
FR2316946A1 (fr) Nouvelles penicillines, leur procede de preparation et medicament les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
BE797100A (fr) Nouveaux triphenylmethylimidozoles leur procede de preparation et medicament les contenant
BE802496A (fr) Nouveaux 2-amino-4h-pyrannes, leur procede de preparation et medicament les contenant
BE808190A (fr) Nouveaux derives tetrazoliques de chromonyloxy-phenoxypropanes leur procede de preparation et medicament les contenant
BE835392A (fr) Nouveaux 1, 1-bioxydes de 4-hydroxy-2hnaphto(2,1-e) -1,2- thiazine - 3 carboxyamides, leur procede de preparation et medicaments les renferment

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAYER A.G.

Effective date: 19840305